| 摘要 |
<p>The present invention relates to a novel use of proton pump inhibitors, such as omeprazole, esomeprazole, lansoprazole, rabeprazole and pantoprazole. More closely, the invention relates to use of proton pump inhibitors (PPIs) for production of a drug for treatment or prevention of a MDR (multidrug resistance) condition, such as a condition associated with cancer treatment.</p> |
